Cases & Deals

Celgene files declaratory judgment action against Cyclacel

Clients Celgene Corporation

Jones Day represents plaintiff Celgene Corporation in a declaratory judgment action for non-infringement and invalidity of four Cyclacel Pharmaceuticals, Inc. patents related to certain depsipeptides and uses thereof. Jones Day also defends Celgene against allegations of infringing the four patents-in-suit by Celgene's marketing of ISTODAX(R) (romidepsin).

Celgene Corporation v. Cyclacel Pharmaceuticals, Inc., Civil Action No. 1-10-cv-00348-GMS (D. Del.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.